0001127602-24-009544.txt : 20240311
0001127602-24-009544.hdr.sgml : 20240311
20240311211124
ACCESSION NUMBER: 0001127602-24-009544
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240310
FILED AS OF DATE: 20240311
DATE AS OF CHANGE: 20240311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Day Daniel Patrick
CENTRAL INDEX KEY: 0001638643
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19731
FILM NUMBER: 24740019
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DRIVE
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GILEAD SCIENCES, INC.
CENTRAL INDEX KEY: 0000882095
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 943047598
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 6505743000
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
FORMER COMPANY:
FORMER CONFORMED NAME: GILEAD SCIENCES INC
DATE OF NAME CHANGE: 19930328
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-03-10
0000882095
GILEAD SCIENCES, INC.
GILD
0001638643
O'Day Daniel Patrick
333 LAKESIDE DRIVE
FOSTER CITY
CA
94404
1
1
Chairman & CEO
0
Common Stock
2024-03-10
4
M
0
10800
A
479489
D
Common Stock
2024-03-10
4
M
0
19140
A
498629
D
Common Stock
2024-03-10
4
F
0
13782
75.12
D
484847
D
Restricted Stock Unit
2024-03-10
4
M
0
10800
D
Common Stock
10800
100092
D
Restricted Stock Unit
2024-03-10
4
M
0
19140
D
Common Stock
19140
80952
D
Non-qualified Stock Option (Right to Buy)
75.12
2024-03-10
4
A
0
279130
0
A
2034-03-10
Common Stock
279130
279130
D
Restricted Stock Unit
2024-03-10
4
A
0
54910
A
Common Stock
54910
135862
D
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.
The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
The options have a four-year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
/s/ Amy Kim by Power of Attorney for Daniel O'Day
2024-03-11